3Q RW 2009 Quality Report
This table presents results for the time period October thru December 2009 (Ryan White Part B Third Quarter) showing the HRSA/HAB Tier 1 Clinical Performance Measures. Because services and client population vary widely in our provider angencies these also show great diversity. Please note additional comments below the chart.
| Service Outcome Measures | CA | DPCHC | PU | SAAF | CTSS | WMCPHD |
| Medical Visits: Percentage of (served) clients with HIV infection who had 2 or more medical visits in an HIV care setting in the measurement year. | 82.5% | 83% | 76.6% | 46.9% | 54.5% | 93.2% |
| CD4 T-cell count: Percentage of (served) clients with HIV infection who had 2 or more CD4 T-cell counts performed in the measurement year. | 88.2% | 81.8% | 65.6% | 77.6% | 40.6% | 93.2% |
| HAART: Percentage of (served) clients with AIDS who were prescribed HAART. | 95.8% | 97.4% | 15% | 93.1% | 95.6% | 100% |
| PCP Prophylaxis: Percentage of (served) clients with HIV infection and a CD4 T-cell count below 200 cells/mm who were prescribed PCP prophylaxis. | 93.8% | 91.7% | 31.6% | 87.5% | 80% | 100.0% |
| ARV Therapy For Pregnant Women: Percentage of (served) pregnant women with HIV infection who are prescribed antiretroviral therapy. | 100% | 60% [100%] | 50% | N/A | N/A | N/A |